A recent 132 hour test of second-generation neutron generator prototype in Wisconsin demonstrates the device is “more than capable” of reliably driving Shine’s medical isotope production. The facility will domestically produce medical isotope Mo-99 with low-enriched uranium instead of high-enriched uranium, a positive step for nuclear security.